Will Fortis undergo a Name Change? IHH to decide
New Delhi: Malaysian firm IHH Healthcare Berhad has recently announced its open offer for acquiring up to 26% stake in Fortis Healthcare is likely to be completed by December-end.
The company also said that it currently has no immediate specific plans to change the brand name of Fortis Healthcare though it has several brands that could be considered if a decision is taken regarding this in future.
When asked when IHH plans to complete the open offer for acquiring up to 26% stake from the existing shareholders in Fortis, IHH Healthcare Berhad MD and CEO Tan See Leng said the company is hopeful of completing it by the end of December.
The IHH CEO had earlier stated that “In the long term and going ahead we would like to rebrand the Fortis hospitals to our own brand, Gleneagles.”
Read Also: Fortis to be renamed as Gleneagles, says IHH Managing Director Tan
“Our most optimistic target is that by the middle of December we will put up the offer and we are cautiously optimistic that by end of December we can complete it,” he added. On plans to change the brand name of FortisHealthcare, he said: " the brand is something we will address when we come to it.”
Speaking about the importance of India for IHH, Tan See Leng said: “India has always been a key growth market for us, It is now one of the fourth home markets for us along with Malaysia, Turkey and Singapore.” IHH will ensure that Fortis forges ahead as a leading healthcare provider in India, he added.
On Tuesday, Fortis Healthcare said it had issued 23.53 crore equity shares through preferential allotment to IHH Healthcare Berhad for around Rs 4,000 crore, a move that helps the Malaysian firm take 31.1% stake in the company.
Read Also: CCI approves IHH acquisition of Fortis Healthcare, Fortis Malar Hospital
The board of Fortis had also approved the appointment of four IHH nominees on the company’s board, it added.
“The acquisition of a controlling stake in Fortis Healthcare, one of the leading healthcare service providers in India, represents a transformational investment for IHH and demonstrates our commitment to invest considerable resources to expand and consolidate our footprint in India,” Tan See Leng had said.
Read Also: IHH Healthcare completes Fortis Acquisition, Appoints 4 Directors on Board
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd